Rain Oncology
About:
Rain Oncology is a operator of a clinical stage biotechnology company.
Website: https://www.rainoncology.com
Twitter/X: Rain_Oncology
Top Investors: Perceptive Advisors, Samsara BioCapital, Cormorant Asset Management, Boxer Capital, Logos Capital
Description:
Rain Oncology Inc. is a precision oncology company developing therapies that target oncogenic drivers to genetically select patients it believes will most likely benefit.
Total Funding Amount:
$82.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Newark, California, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)rainoncology.com
Founders:
Avanish Vellanki, Robert Doebele
Number of Employees:
51-100
Last Funding Date:
2020-09-03
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai